Nguyen _et al. Gut Pathog (2016) 8:39_ Page 5 of 9



**Table 2 Results of cultivation and multiplex PCR identifi-**
**cation of** _**Campylobacter**_ **isolates**


**Cultivation** **mPCR identification of** _**Campylobacter**_ **Total**
**n (%)**
_**C. jejuni C. coli**_ **Not identi‑** _**C. coli/C.**_
**fied** _**jejuni**_


Positive (n) 31 4 5 0 40 (69.0)

Negative (n) 3 14 0 1 18 (31.0)


(MAMA–PCR) was used to characterize a _gyr_ A gene
mutation associated with ciprofloxacin resistance as well
as mutations in 23S rRNA genes as cause of erythromycin
resistance. The molecular biological detection of resistance to ciprofloxacin in both _C. coli_ and _C. jejuni_ was also
confirmed by change of amino acid 86 from threonine to
isoleucine in the _gyr_ A gene. Additional to the ciprofloxacin resistant _Campylobacter_ isolates (Tables 3, 4), three



_Campylobacter_ DNAs were detected harbouring the _gyr_ A
gene mutation. The results were confirmed by PCR–RFLP
according to Vacher et al. [24]. Mutations at positions
2074 and 2075 of the 23S rRNA genes in 13 phenotypically erythromycin-resistant isolates could neither be
detected by using PCR–RFLP nor MAMA–PCR.
The _tet_ (O) gene which is mainly responsible for tetracycline-resistance was detected by PCR in 12 out of 22
resistant _C. jejuni_ isolates (54.5 %) and in all tetracycline
resistant _C. coli_ isolates. _tet_ (O) gene was not detected in
DNA extracted from the non-growing samples. Additionally, a newly developed PCR assay was used for the
detection of the _tet_ (A) gene. _tet_ (A) was detected in 28
out of 31 _C. jejuni_ (90.3 %) and in all 4 _C. coli_ isolates.
In 3 out of 14 non-growing samples which harboured
_C. coli_ DNA, _tet_ (A) gene could be found as well as in
the one sample where both _C. jejuni_ and _C. coli_ were
detected.



















|Table 3 Results of M|MIC determination|n and resistance rates of Kenyan Campylobacter jejuni isolate Antibiotic susceptibility of Campylobacter jejuni|Col4|Col5|Col6|Col7|Col8|Col9|Col10|Col11|Col12|Col13|es R*|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Class|Antibiotic<br>(µg/ml)|~~Antibiotic susceptibility of~~~~_Campylobacter jejuni_~~<br>(n=31)|~~Antibiotic susceptibility of~~~~_Campylobacter jejuni_~~<br>(n=31)|~~Antibiotic susceptibility of~~~~_Campylobacter jejuni_~~<br>(n=31)|~~Antibiotic susceptibility of~~~~_Campylobacter jejuni_~~<br>(n=31)|~~Antibiotic susceptibility of~~~~_Campylobacter jejuni_~~<br>(n=31)|~~Antibiotic susceptibility of~~~~_Campylobacter jejuni_~~<br>(n=31)|~~Antibiotic susceptibility of~~~~_Campylobacter jejuni_~~<br>(n=31)|~~Antibiotic susceptibility of~~~~_Campylobacter jejuni_~~<br>(n=31)|~~Antibiotic susceptibility of~~~~_Campylobacter jejuni_~~<br>(n=31)|~~Antibiotic susceptibility of~~~~_Campylobacter jejuni_~~<br>(n=31)|~~Antibiotic susceptibility of~~~~_Campylobacter jejuni_~~<br>(n=31)|~~R*~~<br>(%)|
|Class|Antibiotic<br>(µg/ml)|0.06|0.12|0.25|0.5|1|2|4|8|16|32|64||
|Macrolides<br>|Chloramphenicol||||||9|3|6|5<br>**_8_**|5<br>**_8_**||~~25.8~~<br>|
|Macrolides<br>|Erythromycin<br>||||14|||1<br>**_2_**|1<br>**_2_**|**_2_**|**_12_**||~~51.6~~<br>|
|~~Fluoroquinolones ~~<br>|Ciprofloxacin|5|2|2|**_2_**|**_2_**|**_1_**|**_19_**|||||~~71.0~~<br>|
|~~Quinolones~~|Nalidixic acid|||||||4|1|2<br>**_2_**|2<br>**_2_**|**_22_**|~~77.4~~<br>|
|Aminoglycosides<br>|Gentamicin||2|1|4|11|5<br>**_2_**|5<br>**_2_**|**_1_**|**_5_**|||~~25.8~~<br>|
|Aminoglycosides<br>|Streptomycin|||||12|2|4<br>**_1_**|4<br>**_1_**|**_12_**|||~~41.9~~<br>|
|~~Tetracyclines~~|Tetracycline|||6|1|2|**_1_**|**_1_**|**_1_**|**_20_**|||~~71.0~~|


Boldface in italic type indicates the number of resistant isolates. A thick black line indicates the break point between clinically sensitive and resistant strains

R* resistance rate

















|Table 4 Results of M|MIC determination|n and resistance rates of Kenyan Campylobacter coli isolates Antibiotic susceptibility of Campylobacter coli|Col4|Col5|Col6|Col7|Col8|Col9|Col10|Col11|Col12|Col13|R*|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Class|Antibiotic<br>(µg/ml)|~~Antibiotic susceptibility of~~~~_Campylobacter coli_~~<br>(n=4)|~~Antibiotic susceptibility of~~~~_Campylobacter coli_~~<br>(n=4)|~~Antibiotic susceptibility of~~~~_Campylobacter coli_~~<br>(n=4)|~~Antibiotic susceptibility of~~~~_Campylobacter coli_~~<br>(n=4)|~~Antibiotic susceptibility of~~~~_Campylobacter coli_~~<br>(n=4)|~~Antibiotic susceptibility of~~~~_Campylobacter coli_~~<br>(n=4)|~~Antibiotic susceptibility of~~~~_Campylobacter coli_~~<br>(n=4)|~~Antibiotic susceptibility of~~~~_Campylobacter coli_~~<br>(n=4)|~~Antibiotic susceptibility of~~~~_Campylobacter coli_~~<br>(n=4)|~~Antibiotic susceptibility of~~~~_Campylobacter coli_~~<br>(n=4)|~~Antibiotic susceptibility of~~~~_Campylobacter coli_~~<br>(n=4)|~~R*~~<br>(%)|
|Class|Antibiotic<br>(µg/ml)|0.06|0.12|0.25|0.5|1|2|4|8|16|32|64||
|Macrolides<br>|Chloramphenicol||||||2|||**_2_**|**_2_**||~~50.0~~<br>|
|Macrolides<br>|Erythromycin<br>||||4||||||||~~0~~<br>|
|~~Fluoroquinolones ~~<br>|Ciprofloxacin|1||||||**_3_**|||||~~75.0~~<br>|
|~~Quinolones~~|Nalidixic acid||||||||1|||**_3_**|~~75.0~~<br>|
|Aminoglycosides<br>|Gentamicin||1||1|1|**_1_**|**_1_**|||||~~25.0~~<br>|
|Aminoglycosides<br>|Streptomycin|||||2||2|2||||~~0~~<br>|
|~~Tetracyclines~~|Tetracycline|||1|1|1||||**_1_**|||~~25.0~~|


Boldface in italic type indicates the number of resistant isolates. A thick black line indicates the break point between clinically sensitive and resistant strains

R* resistance rate


